Operating
Change in Income Taxes
Neurocrine Biosciences Change in Income Taxes increased by 677.9% to $119.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 677.9%, from $15.40M to $119.80M.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryRisk
SignalContext dependent
VolatilityModerate
First reportedQ1 2023
Last reportedQ1 2026May 5, 2026
How to read this metric
Fluctuations are often driven by timing of tax payments and changes in tax regulations rather than operational performance.
Detailed definition
This reflects the change in the company's tax liability or tax receivable balance between periods. It represents the tim...
Peer comparison
Standard across all corporations; highly dependent on global tax jurisdictions and fiscal year-end timing.
Metric ID:
change_in_income_taxesHistorical Data
7 periods
| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|
| Value | $22.90M | $22.90M | $22.90M | $22.90M | $55.10M | $15.40M | $119.80M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +140.6% | -72.1% | +677.9% |
| YoY Change | — | — | — | — | +140.6% | — | +677.9% |
Range$15.40M – $119.80M
CAGR+201.4%
Avg YoY Growth+409.3%
Median YoY Growth+409.3%
Change in Income Taxes at Other Companies
Frequently Asked Questions
- What is Neurocrine Biosciences's change in income taxes?
- Neurocrine Biosciences (NBIX) reported change in income taxes of $119.80M in Q1 2026.
- How has Neurocrine Biosciences's change in income taxes changed year-over-year?
- Neurocrine Biosciences's change in income taxes increased by 677.9% year-over-year, from $15.40M to $119.80M.
- What does change in income taxes mean?
- The change in the amount of taxes owed to or receivable from the government.